CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Basilea Pharmaceutica Limited Company Snapshot
Basilea Pharmaceutica Limited operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Basilea Pharmaceutica Limited with three other miscellaneous service companies in Europe: Pharming Group NV of the Netherlands (2017 sales of 89.62 million Euro [US$109.43 million] of which 100% was Recombinant Proteins), MorphoSys AG of Germany (66.79 million Euro [US$81.55 million] of which 74% was Partnered Discovery), and Karo Pharma AB which is based in Sweden (657.61 million Swedish Kronor [US$77.18 million] ).

Sales Analysis. Basilea Pharmaceutica Limited reported sales of 90.67 million Swiss Francs (US$92.71 million) for the year ending December of 2017. This represents an increase of 39.4% versus 2016, when the company's sales were 65.04 million Swiss Francs. This was the fourth straight year of sales growth at Basilea Pharmaceutica Limited.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Basilea Pharmaceutica Limited
  Stock Performance Chart for Basilea Pharmaceutica Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 68.00
(Figures in Swiss Francs)
1 Week 0.0%   13 Weeks 3.8%  
4 Weeks -12.8%   52 Weeks -16.6%  
 
Basilea Pharmaceutica Limited Key Data:
  Ticker: BSLN Country: Switzerland
  Exchanges: GVA Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 90,674,000
(Year Ending Jan 2018).
Employees: 230
  Currency: Swiss Francs Market Cap: 739,272,608
  Fiscal Yr Ends: December Shares Outstanding: 10,871,656
  Share Type: Namenaktie Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.